Harim Won

Life Science

Why OUP?

I am excited and motivated by OUP’s mission of supporting innovators at our partner institutions, including those seeking to make our world a healthier place. My favorite part of this work is getting to learn from these experts and field leaders about how they are advancing human health through the development of new therapeutics.

Harry is an Associate focusing on life science investment opportunities across therapeutic areas and development stages. Prior to joining OUP, Harry was a Fellow at Flagship Pioneering, where he developed novel company concepts within therapeutics and sustainability. Before that, he was a Fellow at Vida Ventures, contributing to the diligence process for therapeutics investment opportunities.

During graduate school, Harry focused on developing targeted protein degradation as an antibiotic modality for tuberculosis and this work was selected for presentation at the Harvard Horizons symposium. He also served on the leadership of Nucleate as Director of the Innovation Fellowship.

Harry received his Ph.D. in Biological Sciences in Public Health from Harvard University and was supported by the Herchel Smith Graduate Fellowship and the National Science Foundation Graduate Research Fellowship. He also holds a B.S. in Biotechnology from the University of Nebraska at Omaha.


  • BS, University of Nebraska at Omaha
  • PhD, Harvard University